Young‐Tae Bak

An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome

John Kellow, O. Y. Lee, F. Y. Chang et al. · Gut · 2003 · 230 citations

Irritable Bowel Syndrome, Gut Microbiota and Probiotics

Beom Jae Lee, Young‐Tae Bak · Journal of Neurogastroenterology and Motility · 2011 · 225 citations · Full text

Chronic Inflammatory Diseases, Dysbiosis, Immunology +17

Asia‐Pacific consensus on the management of gastroesophageal reflux disease: Update

Kwong Ming Fock, Nicholas J. Talley, Ronnie Fass et al. · Journal of Gastroenterology and Hepatology · 2007 · 189 citations

Clinical Significance of Hiatal Hernia

Jong Jin Hyun, Young‐Tae Bak · Gut and Liver · 2011 · 164 citations · Full text

Esophagus, Hernia Surgery, Medicine +10

PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty‐acid metabolic enzymes

Yeon Seok Seo, Ji Hoon Kim, Nam Young Jo et al. · Journal of Gastroenterology and Hepatology · 2006 · 149 citations